Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 10, 2009, Pages 1078-1085

  Bang, U C ^a   NOjgaard C ^a   Andersen, P K ^b   Matzen, P ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; DIAZEPAM; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; MIDAZOLAM; PETHIDINE; PLACEBO;

ACUTE PANCREATITIS; ARTICLE; CLINICAL TRIAL; DRUG FATALITY; DRUG INDUCED HEADACHE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; HYPOTENSION; INCIDENCE; INFECTION PREVENTION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; NITROGLYCERIN; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 64849098888     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.03978.x     Document Type: Article

References (24)

1. Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006 101 : 139 47.
2. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001 54 : 425 34.
3. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991 101 : 1068 75.
4. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007 5 : 1354 65.
5. Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008 57 : 1262 7.
6. Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007 65 : 624 32.
7. Li ZS, Pan X, Zhang WJ, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 2007 102 : 46 51.
8. Lee KT, Lee DH, Yoo BM. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Pancreas 2008 37 : 445 8.
9. Staritz M, Poralla T, Ewe K, Meyer zum Buschenfelde KH. Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut 1985 26 : 194 7.
10. Moreto M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc 2003 57 : 1 7.
11. Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001 88 : 1178 82.
12. Muralidharan V, Jamidar P. Pharmacologic prevention of post-ERCP pancreatitis: is nitroglycerin a sangreal? Gastrointest Endosc 2006 64 : 358 60.
13. Beauchant M, Ingrand P, Favriel JM, et al. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Endoscopy 2008 40 : 631 6.
14. Kaffes AJ, Bourke MJ, Ding S, et al. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006 64 : 351 7.
15. Shao LM, Chen QY, Chen MY, Cai JT. Nitroglycerin in the prevention of Post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci 2009. (in press).
16. Higgins JPT, Green S editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from http://www.cochrane-handbook.org. 2008.
17. Nøjgaard C, Hornum M, Elkjaer M, et al. Does glyceryl nitrate prevent post-endoscopic retrograde cholangiopancreaticography (ERCP) pancreatitis? Gastrointest.Endosc 2009. (in press)
18. Ghori A, Hallisey M, Nwokolo C, Loft D, Fraser I. The secret (GTN) of successful ERCP cannulation: a prospective randomised controlled study. J R Coll Surg Edinb 2002 47 : 634 7.
19. Luman W, Pryde A, Heading RC, Palmer KR. Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut 1997 40 : 541 3.
20. Talwar A, Dare C, Pain J. Does topical GTN on the sphincter of Oddi facilitate ERCP? A double-blind randomized control trial. Surg Endosc 2005 19 : 902 4.
21. Wehrmann T, Schmitt T, Stergiou N, Caspary WF, Seifert H. Topical application of nitrates onto the papilla of Vater: manometric and clinical results. Endoscopy 2001 33 : 323 8.
22. Wood AM, White IR, Thompson SG. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials 2004 1 : 368 76.
23. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991 37 : 383 93.
24. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007 102 : 1781 8.